An in Silico Study of Selected Compounds from Garcinia spp. to Fight against Multidrug Resistant Bacteria
DOI:
https://doi.org/10.37591/(rrjobi).v4i2.8Abstract
Abstract
Background: Antibiotic resistant bacteria have emerged as a global threat. They have limited the number of available treatment options. New Delhi Metallo-beta-lactamase-1 (NDM-1) mediated drug resistance and efflux pump mediated drug resistance are among the major mechanisms associated with multidrug resistance.
Objective: In our study, potential NDM-1 inhibitors as well as efflux pump inhibitors were identified through reverse chemogenomics from Garcinia spp. to deal with multidrug resistant bacteria.
Method: Selected compounds from Garcinia spp. were screened for inhibitory activity against NDM-1 and efflux pump protein AcrB through subsequent comparative molecular docking. The compounds were filtered through Lipinski filter as well as ADME-Tox filter.
Result: From docking analysis and MIC calculations, it was found that the xanthones have greater potential to act as efflux pump inhibitors than garcinol, as they showed higher docking docking values against AcrB than NDM-1 target protein; while Garcinol showed better scores against NDM-1 target protein. All the ligands possess drug like characters as they passed the Lipinski filter as well as ADME-Tox screening.
Conclusion: From the study, it was seen that Garcinol and xanthones present in Garcinia spp., which possess medicinal value might act as potential inhibitors of efflux pump or NDM-1.
Keywords: Antibiotic resistance, efflux pump, NDM-1, autodock, QSAR, ADMET
Cite this Article
Bonashree Phukan, Partha Sarathi Borah, Seema Barman et al. An in silico study of selected compounds from Garcinia spp. to Fight Against Multidrug Resistant Bacteria. Research & Reviews: A Journal of Bioinformatics. 2017; 4(2): 1–4p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |